Cytek Biosciences Inc (CTKB)
6.125
-0.14
(-2.31%)
USD |
NASDAQ |
May 09, 14:25
Cytek Biosciences Total Assets (Quarterly): 494.46M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 494.46M |
| September 30, 2023 | 519.43M |
| June 30, 2023 | 525.05M |
| March 31, 2023 | 524.58M |
| December 31, 2022 | 519.48M |
| September 30, 2022 | 499.30M |
| June 30, 2022 | 492.82M |
| Date | Value |
|---|---|
| March 31, 2022 | 485.88M |
| December 31, 2021 | 463.30M |
| September 30, 2021 | 454.32M |
| June 30, 2021 | 230.28M |
| March 31, 2021 | 224.26M |
| December 31, 2020 | 219.98M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
219.98M
Minimum
Dec 2020
525.05M
Maximum
Jun 2023
434.86M
Average
492.82M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Ainos Inc | 31.84M |
| OpGen Inc | 18.13M |
| Zomedica Corp | 253.20M |
| LENSAR Inc | 69.58M |
| Eargo Inc (DELISTED) | 69.75M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 101.39M |
| Shareholders Equity (Quarterly) | 393.06M |
| Debt to Equity Ratio | 0.0056 |
| Current Ratio | 6.973 |
| Net Debt Paydown Yield | -0.04% |